BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11472371)

  • 1. Analysis of chimaerism in thalassaemic children undergoing stem cell transplantation.
    Amrolia PJ; Vulliamy T; Vassiliou G; Lawson S; Bryon J; Kaeda J; Dokal I; Johnston R; Veys P; Darbyshire P; Roberts IA
    Br J Haematol; 2001 Jul; 114(1):219-25. PubMed ID: 11472371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype, function and chimaerism of monocyte-derived blood dendritic cells after allogeneic haematopoietic stem cell transplantation.
    Nachbaur D; Kircher B; Eisendle K; Lätzer K; Haun M; Gastl G
    Br J Haematol; 2003 Oct; 123(1):119-26. PubMed ID: 14510953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors.
    Hamblin M; Marsh JC; Lawler M; McCann SR; Wickham N; Dunlop L; Ball S; Davies EG; Hale G; Waldmann H; Gordon-Smith EC
    Bone Marrow Transplant; 1996 May; 17(5):819-24. PubMed ID: 8733704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience.
    Ball LM; Lankester AC; Giordano PC; van Weel MH; Harteveld CL; Bredius RG; Smiers FJ; Egeler RM; Vossen JM
    Bone Marrow Transplant; 2003 Jun; 31(12):1081-7. PubMed ID: 12796787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second transplantation using allogeneic peripheral blood stem cells in a beta-thalassaemia major patient featuring stable mixed chimaerism.
    Or R; Kapelushnik J; Naparstek E; Nagler A; Filon D; Oppenheim A; Amar A; Aker M; Samuel S; Slavin S
    Br J Haematol; 1996 Aug; 94(2):285-7. PubMed ID: 8759888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified conditioning regimen improves outcomes of unrelated donor peripheral blood stem cell transplantation for β-thalassaemia major patients.
    Huang K; Zhou DH; Li Y; Xu HG; Que LP; Chen C; Xue HM; Guo HX; Weng WJ; Huang SL; Fang JP
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27026. PubMed ID: 29512932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second Hematopoietic Stem Cell Transplant for Thalassemia Major: Improved Clinical Outcomes with a Treosulfan-Based Conditioning Regimen.
    Korula A; Pn N; Devasia A; Lakshmi KM; Abraham A; Sindhuvi E; George B; Srivastava A; Mathews V
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):103-108. PubMed ID: 29032269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second transplant for a thalassemia patient after graft rejection: with immunosuppression and allogeneic peripheral blood stem cell.
    Li CK; Shing MM; Chik KW; Lee V; Tsang KS; Yuen PM
    Pediatr Hematol Oncol; 2002 Jun; 19(4):267-71. PubMed ID: 12051594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative serial quantitative measurements of chimaerism following unmanipulated allogeneic transplantation of peripheral blood stem cells and bone marrow.
    Miflin G; Stainer CJ; Carter GI; Byrne JL; Haynes AP; Russell NH
    Br J Haematol; 1999 Nov; 107(2):429-40. PubMed ID: 10583237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection.
    Matthes-Martin S; Lion T; Haas OA; Frommlet F; Daxberger H; König M; Printz D; Scharner D; Eichstill C; Peters C; Lawitschka A; Gadner H; Fritsch G
    Leukemia; 2003 Oct; 17(10):1934-42. PubMed ID: 14513041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between mixed chimerism and rejection after bone marrow transplantation in thalassaemia.
    Andreani M; Testi M; Battarra M; Indigeno P; Guagnano A; Polchi P; Federici G; Lucarelli G
    Blood Transfus; 2008 Jul; 6(3):143-9. PubMed ID: 18705238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation.
    Mattsson J; Uzunel M; Brune M; Hentschke P; Barkholt L; Stierner U; Aschan J; Ringdén O
    Br J Haematol; 2001 Dec; 115(4):935-44. PubMed ID: 11843830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of chimaerism analysis and kinetics on allogeneic haematopoietic stem cell transplantation outcome after conventional and reduced-intensity conditioning regimens.
    Michallet AS; Fürst S; Le QH; Dubois V; Praire A; Nicolini F; Thomas X; Rafii H; Gebuhrer L; Michallet M
    Br J Haematol; 2005 Mar; 128(5):676-89. PubMed ID: 15725090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lineage-specific engraftment and outcomes after T-cell-depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning.
    Montero A; Savani BN; Kurlander R; Read EJ; Leitman SF; Childs R; Solomon SR; Barrett AJ
    Br J Haematol; 2005 Sep; 130(5):733-9. PubMed ID: 16115130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J
    Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OKT-3-based reconditioning regimen for early graft failure in HLA-non-identical stem cell transplants.
    Schlegel PG; Eyrich M; Bader P; Handgretinger R; Lang P; Niethammer D; Klingebiel T
    Br J Haematol; 2000 Nov; 111(2):668-73. PubMed ID: 11122120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation.
    Bishop MR; Steinberg SM; Gress RE; Hardy NM; Marchigiani D; Kasten-Sportes C; Dean R; Pavletic SZ; Gea-Banacloche J; Castro K; Hakim F; Krumlauf M; Read EJ; Carter C; Leitman SF; Fowler DH
    Br J Haematol; 2004 Sep; 126(6):837-43. PubMed ID: 15352988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of graft status following allogeneic bone marrow transplantation for haematological disorders in children using locus-specific minisatellite probes.
    Katz F; Hann I; Kinsey S; Ball S; Morgan G; Chessells J
    Br J Haematol; 1993 Mar; 83(3):473-9. PubMed ID: 8485054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective molecular study of chimaerism in patients with haematological malignancies receiving unrelated cord blood or bone marrow transplants: detection of mixed chimaerism predicts graft failure with or without early autologous reconstitution in cord blood recipients.
    Cimino G; Rapanotti MC; Elia L; Iori AP; Guglielmi C; Screnci M; Carmini D; De Felice L; Moleti ML; Mengarelli A; Mandelli F; Arcese W
    Br J Haematol; 1999 Mar; 104(4):770-7. PubMed ID: 10192439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparate lympho-erythroid donor to recipient chimaerism in a beta(0)-thalassaemia bone marrow transplant recipient with red cell indices indicative of apparent full engraftment.
    Weinberg RS; Vlachos A; Najfeld V; Galperin Y; Scalise A; Fruchtman S; Lipton JM
    Br J Haematol; 1997 Oct; 99(1):61-3. PubMed ID: 9359504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.